By Megan Brooks
NEW YORK (Reuters Health) Apr 20 - The practice of empirically interrupting chronic aspirin therapy before surgery "should be abandoned," according to the authors of a contemporary literature review.
They say the evidence they found in a PubMed and Medline literature search "strongly supports" continued perioperative use of aspirin in patients taking it for secondary prevention of coronary artery disease, cerebrovascular disease, and peripheral vascular disease.
"Many patients need to be on lifelong aspirin therapy for various cardiovascular indications and...other than for a select group of operative procedures, the risks of aspirin cessation exceed the benefit," Dr. Neal Stuart Gerstein from the Department of Anesthesiology and Critical Care Medicine, University of New Mexico in Albuquerque told Reuters Health by email.
No comments:
Post a Comment